Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients

Bibliographic Details
Title: Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients
Authors: Eun Young Kim, Kwan Ho Lee, Ji-Sup Yun, Yong Lai Park, Chan Heun Park, Sung Yoon Jang, Jai Min Ryu, Se Kyung Lee, Byung-Joo Chae, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Jong Han Yu
Source: BMC Women's Health, Vol 24, Iss 1, Pp 1-13 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Gynecology and obstetrics
LCC:Public aspects of medicine
Subject Terms: Breast neoplasms, Mammography, Microcalcification, Neoadjuvant, Recurrence, Gynecology and obstetrics, RG1-991, Public aspects of medicine, RA1-1270
More Details: Abstract Background Residual microcalcifications after neoadjuvant chemotherapy (NAC) are challenging for deciding extent of surgery and questionable for impact on prognosis. We investigated changes in the extent and patterns of microcalcifications before and after NAC and correlated them with pathologic response. We also compared prognosis of patients depending on presence of residual microcalcifications after NAC. Methods A total of 323 patients with invasive breast carcinoma treated with neoadjuvant chemotherapy at Kangbuk Samsung Hospital and Samsung Medical center from March 2015 to September 2018 were included. Patients were divided into four groups according to pathologic response and residual microcalcifications. Non-pCRw/mic group was defined as breast non-pCR with residual microcalcifications. Non-pCRw/o mic group was breast non-pCR without residual microcalcifications. pCRw/mic group was breast pCR with residual microcalcifications. pCRw/o mic group was breast pCR without residual microcalcifications. The first aim of this study is to investigate changes in the extent and patterns of microcalcifications before and after NAC and to correlate them with pathologic response. The second aim is to evaluate oncologic outcomes of residual microcalcifications according to pathologic response after NAC. Results There were no statistical differences in the extent, morphology, and distribution of microcalcifications according to pathologic response and subtype after NAC (all p > 0.05). With a median follow-up time of 71 months, compared to pCRw/o mic group, the hazard ratios (95% confidence intervals) for regional recurrence were 5.190 (1.160–23.190) in non-pCRw/mic group and 5.970 (1.840–19.380) in non-pCRw/o mic group. Compared to pCRw/o mic group, the hazard ratios (95% CI) for distant metastasis were 8.520 (2.130–34.090) in non-pCRw/mic group, 9.120 (2.850–29.200) in non-pCRw/o mic group. Compared to pCRw/o mic, the hazard ratio (95% CI) for distant metastasis in pCRw/mic group was 2.240 (0.230–21.500) without statistical significance (p = 0.486). Conclusions Regardless of residual microcalcifications, patients who achieved pCR showed favorable long term outcome compared to non-pCR group.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1472-6874
Relation: https://doaj.org/toc/1472-6874
DOI: 10.1186/s12905-024-02973-9
Access URL: https://doaj.org/article/4f6eab04b1144f0ba03d62523d0e4661
Accession Number: edsdoj.4f6eab04b1144f0ba03d62523d0e4661
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14726874
DOI:10.1186/s12905-024-02973-9
Published in:BMC Women's Health
Language:English